CDC

CDC
  • 文章类型: Journal Article
    CD44是I型跨膜糖蛋白,与多种实体瘤的不良预后相关。由于CD44通过调节细胞粘附在肿瘤发展中起关键作用,生存,增殖和干性,它被认为是肿瘤治疗的靶点。抗CD44单克隆抗体(mAb)已被开发并应用于抗体-药物缀合物和嵌合抗原受体-T细胞疗法。抗泛CD44单克隆抗体,C44Mab‑5和C44Mab‑46可识别CD44标准(CD44s)和变体同种型,是以前开发的。本研究产生了小鼠IgG2a版本的抗泛CD44mAb(5‑mG2a和C44Mab‑46‑mG2a),以评估针对CD44阳性细胞的抗肿瘤活性。在流式细胞术中,5‑mG2a和C44Mab‑46‑mG2a均可识别CD44s过表达的CHO‑K1(CHO/CD44s)细胞和食管肿瘤细胞系(KYSE770)。此外,在CHO/CD44s细胞存在下,5‑mG2a和C44Mab‑46‑mG2a均可激活效应细胞,并对CHO/CD44和KYSE770细胞均表现出补体依赖性细胞毒性.此外,与对照小鼠IgG2a相比,给予5‑mG2a和C44Mab‑46‑mG2a显著抑制CHO/CD44和KYSE770异种移植肿瘤的发展。这些结果表明,5-mG2a和C44Mab-46-mG2a可以对CD44阳性癌症发挥抗肿瘤活性,是一种有前途的肿瘤治疗方案。
    CD44 is a type I transmembrane glycoprotein associated with poor prognosis in various solid tumors. Since CD44 plays a critical role in tumor development by regulating cell adhesion, survival, proliferation and stemness, it has been considered a target for tumor therapy. Anti‑CD44 monoclonal antibodies (mAbs) have been developed and applied to antibody‑drug conjugates and chimeric antigen receptor‑T cell therapy. Anti-pan‑CD44 mAbs, C44Mab‑5 and C44Mab‑46, which recognize both CD44 standard (CD44s) and variant isoforms were previously developed. The present study generated a mouse IgG2a version of the anti‑pan‑CD44 mAbs (5‑mG2a and C44Mab‑46‑mG2a) to evaluate the antitumor activities against CD44‑positive cells. Both 5‑mG2a and C44Mab‑46‑mG2a recognized CD44s‑overexpressed CHO‑K1 (CHO/CD44s) cells and esophageal tumor cell line (KYSE770) in flow cytometry. Furthermore, both 5‑mG2a and C44Mab‑46‑mG2a could activate effector cells in the presence of CHO/CD44s cells and exhibited complement-dependent cytotoxicity against both CHO/CD44s and KYSE770 cells. Furthermore, the administration of 5‑mG2a and C44Mab‑46‑mG2a significantly suppressed CHO/CD44s and KYSE770 xenograft tumor development compared with the control mouse IgG2a. These results indicate that 5‑mG2a and C44Mab‑46‑mG2a could exert antitumor activities against CD44‑positive cancers and be a promising therapeutic regimen for tumors.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    大麻是美国青少年中使用最多的非法药物。这项研究的目的是确定大麻使用与其他危险行为之间的关联,包括自杀,在高中生中。这是一项使用2021年密西西比州青年风险行为监测系统(YRBS)的横断面研究。将2021年YRBS数据集合并用于本研究。使用R中的调查软件包生成具有95%置信区间的粗比值比(OR)和调整后的比值比(AOR),以说明权重和YRBS数据的复杂抽样设计。单变量分析确定了与当前大麻使用显着相关的7种危险行为,包括在学校校园携带武器,自杀企图,电子蒸汽使用,目前吸烟,当前饮酒,性行为,无人监督的孩子。在多变量分析中,在调整性别后,种族,学生成绩,和其他危险行为,大麻使用的统计显著变量包括电子蒸汽的当前使用,目前吸烟,当前饮酒,和性行为。密西西比州高中学生的男性和女性之间以及所有种族类别之间的大麻使用负担均匀。确定的关联似乎表明电子蒸汽,烟草制品,和酒精使用可能是药物使用的先行者,应在药物使用预防计划中进行相应的处理。
    Cannabis is the most used illicit drug among youths in the United States. The objectives of this study were to identify the association between cannabis use and other risk behaviors, including suicidality, among high school students. This is a cross-sectional study using the 2021 Mississippi Youth Risk Behavior Surveillance System (YRBS). The 2021 YRBS data sets were combined for this study. The crude odds ratio (OR) and adjusted odds ratio (AOR) with a 95% confidence interval were generated using the survey packages in R to account for weights and the complex sampling design of the YRBS data. Univariate analysis identified seven risky behaviors that were significantly associated with current cannabis use, including carrying weapons on school campuses, suicidal attempts, electronic vapor use, current smoking, current drinking, sexual behaviors, and unsupervised children. In multivariable analysis, after adjusting for gender, race, students\' grades, and other risky behaviors, statistically significant variables for cannabis use included current use of electronic vapor, current smoking, current drinking, and sexual behaviors. Cannabis use is evenly burdened between males and females and between all race categories among Mississippi high school students. The identified associations seem to indicate that electronic vapor, tobacco products, and alcohol use could be the forerunners for drug use and should be treated accordingly in drug use prevention programs.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    喀麦隆面临巨大的清洁能源可及性挑战,尽管丰富的能源资源和大量的游离油棕残留物(OPR)产生,但每年从喀麦隆开发公司(CDC)等农业工业公司倾倒。目前,电力供应主要来自水电(73%),城市和农村地区的可及性分别为65%和14%,虽然能源结构历来由传统的生物质燃料如木柴和木炭主导,占全国能源消费总量的76%以上。水电供应不正常,因为它取决于天气条件,这对经济产生了负面影响。随着喀麦隆在2035年成为新兴经济体,过去十年能源需求的增加加剧了这种情况。然而,为能源领域的研究人员和投资者制定了鼓励政策,以期到2035年实现可再生能源(RE)的25%份额。OPR是一种潜在的(RE)资源,但需要技术评估和技术转化为清洁能源,而不是倾销。这构成了严重的环境问题。这项研究评估了CDC每年产生的OPR数量,并通过咨询CDC统计局的水果收获记录和炸弹量热法分别估算了2004年至2018年的清洁能源价值。重要的发现表明,每年生产203666T的OPR,热值为896TJ,对应于249MWh的电能电势。能源可以被行业使用或注入电网以缓解当前的能源挑战。
    Cameroon faces enormous clean energy accessibility challenges despite abundant energy resources and huge quantities of free oil palm residues (OPR) generated but dumped yearly from the agro-industrial companies like the Cameroon Development Corporation (CDC). Presently, electricity supply is mainly from hydro (73 %) with accessibility of 65 % and 14 % for urban and rural areas respectively, while energy mix is historically dominated by traditional biomass fuels such as firewood and charcoal, accounting for more than 76 % of the country\'s total energy consumption. The hydro supply is not regular as it depends on weather conditions and this has negatively impacted the economy. The situation is aggravated by the increased energy demand over the past decade as Cameroon has engaged to become an emerging economy by 2035. However, encouraging policies for researchers and investors in the energy sector have been put in place with a view of attaining a 25 % share of renewable energy (RE) by 2035. OPR are a potential (RE) resource but require technical assessment and technological transformation into clean energy rather than dumping, which constitutes a serious environmental problem. This research has assessed the quantity of OPR generated annually at the CDC and estimated its clean energy value from 2004 to 2018 by consulting fruits-harvest records from CDC statistics office and by bomb calorimetry respectively. The significant findings reveal a yearly production of 203666T of OPR with a calorific value of 896 TJ, corresponding to electrical energy potential of 249 MWh. The energy could be used by the industry or injected into the grid to mitigate the current energy challenges.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    2023年1月24日,欧洲移植引入了肾脏和胰腺分配的虚拟交叉匹配,作为供体中心物理补体依赖性细胞毒性(CDC)交叉匹配的更好选择,这与较长的冷缺血时间和假阳性反应有关。暂时,作为最终的组织相容性检查,在受援中心的实际CDC交叉匹配将继续进行.虽然欧洲移植肯定不是第一个引入虚拟交叉匹配的器官分配组织,介绍了几个新颖的方面,例如,除了血清学广泛和分裂水平外,在第二领域水平上计算11个基因座上的虚拟小组反应性抗体(vPRA),使用组织免疫遗传学标记语言(HML)文件格式的电子HLA分型数据传输,和基于模棱两可的实际虚拟交叉匹配,供体在所有11个基因座上的第二场HLA分型。这个简短的交流将集中在欧洲移植中虚拟交叉比赛的这些新颖方面。
    On 24 January 2023, Eurotransplant has introduced the virtual crossmatch for kidney and pancreas allocation as a better alternative for the physical Complement Dependent Cytotoxicity (CDC) crossmatches at the donor centre, which were associated with a longer cold ischaemia time and false positive reactions. For the time being, the physical CDC crossmatch at the recipient centre will remain in place as the final histocompatibility check. While Eurotransplant is certainly not the first organ allocation organisation to introduce virtual crossmatching, several novel aspects have been introduced, such as calculation of the virtual panel reactive antibody (vPRA) on 11 loci at the second-field level in addition to the serological broad and split level, electronic HLA typing data transmission using Histoimmunogenetics Markup Language (HML) file format, and the actual virtual crossmatch based on ambiguous, second-field HLA typing of the donor on all 11 loci. This short communication will focus on these novel aspects of the virtual crossmatch in Eurotransplant.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    COVID-19大流行强调了全球微生物实验室生物安全的至关重要性。作为回应,中国加大了努力,加强其疾病控制和预防中心(CDC)实验室内的生物安全措施。这项研究首次对各省的生物安全实践进行了全面评估,城市,和县级CDC微生物实验室。
    我们从2021年到2023年进行了一项全国性的横断面调查,针对的是中国各级行政管理中心内微生物实验室的工作人员。采用分层抽样来选择受访者,确保跨不同CDC层次结构的代表性组合,职称,和学历。该调查包括有关生物安全培训的问题,BSL-2和BSL-3实验室的存在,遵守一般生物安全准则,以及关于标本的管理实践,试剂、和消耗品。进行统计分析以确定不同CDC水平之间生物安全实践的显着差异。
    共收到990份有效回复,强调了BSL-2实验室几乎普遍存在(98.69%),以及CDC网络中BSL-3实验室的显着但不同的存在。调查显示,生物安全培训水平很高(98.69%),并且遵守了生物安全协议。然而,在某些安全实践的一致应用中仍然存在挑战,特别是在较低的行政级别。在标本管理方面存在显著差异,试剂、和消耗品指出了在确保生物安全方面需要改进的领域。
    我们的研究结果表明,中国疾病预防控制中心微生物实验室的生物安全实践奠定了坚实的基础,反映了生物安全法实施后的重大进展。然而,遵守特定协议的可变性强调了持续培训的必要性,资源分配,和政策细化,以在各级统一提高生物安全标准。这项研究的见解对于指导实验室生物安全的未来改进至关重要,不仅在中国,而且可能在其他国家加强其公共卫生基础设施。
    UNASSIGNED: The COVID-19 pandemic underscored the critical importance of biosafety in microbiology laboratories worldwide. In response, China has ramped up its efforts to enhance biosafety measures within its Centers for Disease Control and Prevention (CDC) laboratories. This study provides the first comprehensive assessment of biosafety practices across provincial, city, and county levels of CDC microbiology laboratories in China.
    UNASSIGNED: We conducted a nationwide cross-sectional survey from 2021 to 2023, targeting staff from microbiology laboratories within CDCs at all administrative levels in China. Stratified sampling was employed to select respondents, ensuring a representative mix across different CDC hierarchies, job titles, and academic qualifications. The survey encompassed questions on biosafety training, the presence of BSL-2 and BSL-3 laboratories, adherence to general biosafety guidelines, and management practices regarding specimens, reagents, and consumables. Statistical analysis was performed to identify significant differences in biosafety practices among different CDC levels.
    UNASSIGNED: A total of 990 valid responses were received, highlighting a nearly universal presence (98.69%) of BSL-2 laboratories and a significant yet varied presence of BSL-3 laboratories across the CDC network. The survey revealed high levels of biosafety training (98.69%) and adherence to biosafety protocols. However, challenges remain in the consistent application of certain safety practices, especially at lower administrative levels. Notable differences in the management of specimens, reagents, and consumables point to areas for improvement in ensuring biosecurity.
    UNASSIGNED: Our findings indicate a robust foundation of biosafety practices within CDC microbiology laboratories in China, reflecting significant advancements in the wake of the Biosecurity Law\'s implementation. Nevertheless, the variability in adherence to specific protocols underscores the need for ongoing training, resources allocation, and policy refinement to enhance biosafety standards uniformly across all levels. This study\'s insights are crucial for guiding future improvements in laboratory biosafety, not just in China but potentially in other countries enhancing their public health infrastructures.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:新描述的炎症负担指数(IBI)反映了患者的炎症负担。本研究旨在估计IBI,骨关节炎(OA),以及OA患者的全因死亡率。
    方法:我们从1999年至2018年的国家健康和营养调查数据库中提取了成年人的数据。在使用适当的调查权重校正样本偏差后,我们进行了多变量逻辑回归分析,以探索IBI和OA在三个模型之间的关联:在未调整模型中,部分调整模型(调整年龄,性别,种族,教育水平,婚姻状况,PIR,BMI,吸烟状况,饮酒状况,中风,CVD,DM,和高血压)和完全调整模型(包括其他变量:HBA1C,ALT,AST,BUN,TC,和HDL)。计算比值比(OR)和95%置信区间(CI)。同样,使用可比的调查权重和协变量调整,我们采用Cox比例风险回归分析来研究其他3个模型中IBI与全因死亡率之间的关系.拟合Cox比例风险回归模型以计算IBI与全因死亡率之间关联的风险比(HR)和95%CI。使用受限三次样条(RCS)来探索关联效应之间的非线性关系。进行亚组分析以验证其效果的可靠性。
    结果:总计,包括22,343名合格参与者。多元逻辑回归模型显示,IBI最高的参与者的OA风险是模型1中IBI最低的参与者的2.54倍(95CI,2.23,2.90),而模型2中的OR为1.21(95CI,1.03,1.42),模型3中的OR为1.23(95CI,1.05,1.45)。多重Cox回归模型显示,IBI最高的参与者发生全因死亡的风险是模型1中IBI最低的参与者的186%(95CI,1.50,2.31)倍。这一趋势在模型2中保持稳定(HR,1.54;95CI,1.22,1.95)和3(HR,1.41;95CI,1.10,1.80)。RCS显示IBI和OA风险之间存在显著正相关。关于IBI和全因死亡率之间的关联,从IBI的最低四分位数到第二四分位数观察到死亡率略有下降,死亡风险随着IBI的增加而增加。亚组分析显示,年龄,心血管疾病,高血压在IBI与全因死亡率的关系中至关重要,而IBI与OA的关联在性别等其他因素分层后保持稳定,种族,教育水平,婚姻,吸烟,和饮酒状况,高血压,和大多数血清学指标。
    结论:这项研究提供了IBI,OA,和全因死亡率。IBI可能是评估OA患者炎症负担的一个有希望的标志,which,反过来,有利于高危人群识别的精确参考,抗炎指导,减少死亡率干预。
    BACKGROUND: The newly described inflammatory burden index (IBI) reflects a patient\'s inflammatory burden. This study aimed to estimate the association between IBI, osteoarthritis (OA), and all-cause mortality in patients with OA.
    METHODS: We extracted the data of adults from the National Health and Nutrition Examination Survey database between 1999 and 2018. After using appropriate survey weights to correct for sample bias, we conducted multivariate logistic regression analyses to explore the association between IBI and OA across three models: in the unadjusted model, partially adjusted model (adjusting age, sex, race, education level, marital status, PIR, BMI, smoking status, drinking status, stroke, CVD, DM, and hypertension) and fully adjusted model (which included additional variables: HBA1C, ALT, AST, BUN, TC, and HDL). And the odds ratios (OR) and 95% confidence intervals (CI) were calculated. Similarly, using comparable survey weights and covariates adjustments, we employed Cox proportional hazards regression analysis to investigate the association between IBI and all-cause mortality in the other 3 models. The Cox proportional hazards regression models were fitted to calculate the hazard ratios (HR) and 95% CI of the association between IBI and all-cause mortality. A restricted cubic spline (RCS) was used to explore the nonlinear relationships between association effects. Subgroup analysis was performed to validate the reliability of their effects.
    RESULTS: In total, 22,343 eligible participants were included. Multiple logistic regression models revealed that participants with the highest IBI had 2.54 times (95%CI, 2.23, 2.90)) higher risk of OA than those with the lowest IBI in Model 1, whereas the OR was 1.21 (95%CI, 1.03, 1.42) in Model 2 and 1.23 (95%CI,1.05, 1.45) in Model 3. Multiple Cox regression models showed participants with the highest IBI had 186% (95%CI, 1.50, 2.31) times risk of developing all-cause death than those with the lowest IBI in Model 1. This trend remained stable in Models 2 (HR,1.54; 95%CI,1.22, 1.95) and 3 (HR, 1.41; 95%CI, 1.10, 1.80). The RCS revealed a significant positive association between IBI and OA risk. With respect to the association between IBI and all-cause mortality, a slight decrease in mortality was observed from the lowest quartile to the second quartile of IBI, and the mortality risk increased with increasing IBI. Subgroup analyses showed that age, cardiovascular disease, and hypertension were pivotal in the association of IBI with all-cause mortality, whereas the association of IBI with OA remained stable after stratification by other factors such as sex, race, education level, marital, smoking, and drinking status, hypertension, and most serological indices.
    CONCLUSIONS: This study provides evidence of a positive association between IBI, OA, and all-cause mortality. IBI may be a promising signature for assessing the inflammatory burden in patients with OA, which, in turn, is conducive to precise references for high-risk population recognition, anti-inflammatory guidance, and reducing mortality intervention.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:疾病控制和预防中心(CDC)的绩效评估对于提高公共卫生服务质量至关重要。随着我国疾控中心体制改革的不断深入,现有的绩效评价体系面临挑战。本研究采用德尔菲法建立了一套新的我国省级绩效评价体系,城市,县级疾控中心。
    方法:遵循“结构-过程-结果”模型,系统收集评估指标。根据CDC的职责,通过两轮Delphi对指标进行了修改和筛选,健康发展,和国家政策。二十四位专家提供评级和建议,研究小组评估了问卷的可靠性,专家积极性,专家权威,和意见的一致性。
    结果:通过文献综述和预调查确定的初步指标体系包括11个主要的,30次,和64个三级指标。经过第一轮磋商,删除了两个二级指标和11个三级指标,增加了22个三级指标。第二轮磋商后,删除了三个二级指标和11个三级指标,增加了三个三级指标,此时,肯德尔协调系数W检验的p值<0.001,变异系数在可接受的范围内(<0.25),所以磋商结束了。最终的指标体系包括11个主要的,25次,67项三级指标。
    结论:本研究针对疾病预防控制中心体制改革,建立了省级综合绩效评价指标体系,城市,和中国县级疾控中心。指标体系既科学基础又实用,作为促进疾病预防控制中心组织高质量工作的有效工具。
    The performance evaluation of the Centers for Disease Control and Prevention (CDC) is crucial for enhancing the quality of public health services. With the ongoing reform of the CDC system in China, the existing performance evaluation system faces challenges. This study used the Delphi method to develop a new performance evaluation system for China\'s provincial, city, and county-level CDC.
    Following the \"Structure-Process-Outcome\" model, assessment indicators were systematically collected. Indicators were modified and screened through two Delphi rounds based on CDC responsibilities, health development, and national policies. Twenty-four experts provided ratings and recommendations, and the research team evaluated questionnaire reliability, expert positivity, expert authority, and opinion consistency.
    The preliminary index system identified through the literature review and pre-survey included 11 primary, 30 secondary, and 64 tertiary indicators. After the first round of consultation, two secondary indicators and 11 tertiary indicators were removed and 22 tertiary indicators were added. After the second round of consultation, three secondary indicators and 11 tertiary indicators were removed and three tertiary indicators were added, at which point the p-value of the test for Kendall\'s coefficient of concordance W was < 0.001 and the coefficient of variation was within acceptable limits (< 0.25), so the consultation was concluded. The final index system included 11 primary, 25 secondary, and 67 tertiary indicators.
    This study responded to the CDC system reform by developing a comprehensive performance evaluation index system for provincial, city, and county-level CDC in China. The index system is both scientifically grounded and practical, serving as an effective tool for promoting the high-quality work of CDC organizations.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:与卡塔尔国的成年人相比,我们对学龄儿童中SARS-CoV-2的年龄依赖性流行病学动态的理解存在差距。此外,对及时实施物理距离干预措施的评估有限,尤其是全国学校关闭,以及它们对感染趋势的影响。
    方法:我们使用国家数据库来捕获聚合酶链反应(PCR)测试的所有记录,和快速抗原测试(RAT)在卡塔尔的所有卫生保健场所进行,并在2020年8月26日至2022年8月21日期间在所有年龄组(≥5岁)进行。18岁以下的研究参与者分为两个年龄段:(5-11)和(12-17),与卡塔尔的小学和预备/中学年级保持一致,分别。我们评估了年龄组的测试率,发病率,和相对于成年人的阳性率。将这些流行病学指标与CDC的COVID-19社区传播阈值进行了比较。
    结果:在2020-2021和2021-2022的整个学年中,分别进行了总共5,063,405和6,130,531项测试。在2020-2021学年,89.6%的测试是针对成年人,而13.7%是在第二年对儿童进行的。2020-2021和2021-2022学年的总体测试阳性率分别为5.8%和8.1%,分别。与成人和幼儿相比,青少年在整个研究期间接受的测试最少。使用CDC指标,我们发现儿童和青少年可以显著提高感染率,放松社会限制后可能会推动社区传播。
    结论:在制定传播控制策略和做出关闭学校的决定时,必须承认青年和青少年之间传播程度较高的可能性。采用数据驱动的指标和阈值来监测COVID-19社区水平对于告知决策非常重要。这些方法还可以在未来的大流行中迅速实施感染控制传播缓解措施。
    BACKGROUND: There exists a gap in our understanding of the age-dependent epidemiological dynamics of SARS-CoV-2 among school-age children in comparison to adults within the State of Qatar. Additionally, there has been limited assessment of the timely implementation of physical distancing interventions, notably national school closures, and their impact on infection trends.
    METHODS: We used the national database to capture all records of polymerase-chain-reaction (PCR) testing, and rapid antigen tests (RAT) conducted at all health care venues in Qatar and administered between August 26, 2020, and August 21, 2022, across all age groups (≥ 5 years old). Study participants under 18 years old were categorized into two age brackets: (5-11) and (12-17), aligning with the Primary and Preparatory/Secondary grade levels in Qatar, respectively. We assessed age group testing rates, incidence rates, and positivity rates in relation to adults. These epidemiological metrics were compared with the CDC\'s thresholds for COVID-19 community transmission.
    RESULTS: Throughout the school years of 2020-2021 and 2021-2022, a total of 5,063,405 and 6,130,531 tests were respectively conducted. In the 2020-2021 school year, 89.6% of the tests were administered to adults, while 13.7% were conducted on children in the following year. The overall test positivity rates for the 2020-2021 and 2021-2022 school years were 5.8% and 8.1%, respectively. Adolescents underwent the fewest tests during the full study period compared to both adults and young children. Using the CDC indicators, we found that children and adolescents can significantly contribute to elevated infection rates, potentially driving community transmission upon relaxation of social restrictions.
    CONCLUSIONS: It is crucial to acknowledge the potential for higher transmission among youth and adolescents when formulating transmission control strategies and making decisions regarding school closures. Employing data-driven indicators and thresholds to monitor COVID-19 community levels is important for informing decision-making. These approaches also enable the prompt implementation of infection control transmission mitigation measures in future pandemics.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    疾病控制和预防中心(CDC)自闭症和发育障碍监测(ADDM)网络的2020年患病率报告的最新发现表明,黑人和白人青年之间自闭症诊断的差异已经缩小,反映了改进的筛选,意识,和获得服务(Maenner等人,,2023年。发病率和死亡率周报。监视摘要(华盛顿,D.C.C.:2002),72,1-14。).声称将差距缩小到患病率之外,然而,不完全支持,正如现实情况所表明的那样,筛查表明自闭症特征的黑人青年仍然没有以与白人同龄人相同的速度被推荐进行全面评估或早期干预服务(Major等人。,2020年。自闭症,24,1629-1638;史密斯等人。,2020年。儿科,145,S35-S46。).被确定为自闭症的8岁黑人仍然经历着不同的教育位置(Waitoller等人。,2010.特殊教育杂志。44,29-49。)其中服务可能不是针对自闭症的,或者个人教育计划的目标只关注“行为问题”(Severini等人。,2018.自闭症和发育障碍杂志,48,3261-3272。),在最严格的环境中使用(Skiba等人。,2006.特殊的孩子,72,411-424。),并且缺乏一致的增强和替代沟通支持(Pope等人。,2022年。美国语言病理学杂志,31,2159-2174。).此外,ADMM研究人员报告说,在确定共同发生的智力障碍方面存在一致的差异,其中黑人自闭症儿童的共同发生比白人自闭症儿童明显更多。本评注的目的是首先审查这样一种说法,即差距缩小表明,\“...改善了...历史上服务不足的群体获得服务的机会,\“(第9)(Maenner等人。,2023年。发病率和死亡率周报。监视摘要(华盛顿,D.C.C.:2002),72,1-14。).然后,我们将建议解决持续存在的差距的战略。
    Recent findings from the Centers for Disease Control and Prevention\'s (CDC) Autism and Developmental Disabilities Monitoring (ADDM) Network\'s 2020 prevalence report indicate that disparities in autism diagnoses between Black and White youth have narrowed, reflecting improved screening, awareness, and access to services (Maenner et al., 2023. Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C.: 2002), 72, 1-14.). Claims of reducing disparities beyond prevalence rates, however, are not fully supported, as indicated by the reality that Black youth whose screenings indicate autistic traits are still not being referred for full evaluation or early intervention services at the same rate as their White peers (Major et al., 2020. Autism, 24, 1629-1638; Smith et al., 2020. Pediatrics, 145, S35-S46.). Black 8-year-olds identified as autistic still experience disparate educational placements (Waitoller et al., 2010. The Journal of Special Education. 44, 29-49.) where services may not be autism-specific or have Individual Education Plan goals only focused on \"behavior problems\" (Severini et al., 2018. Journal of Autism and Developmental Disorders, 48, 3261-3272.), are served in the most restrictive environments (Skiba et al., 2006. Exceptional Children, 72, 411-424.) and lack consistent augmentative and alternative communication support (Pope et al., 2022. American Journal of Speech-Language Pathology, 31, 2159-2174.). Additionally, ADMM researchers report consistent disparities in the identification of co-occurring intellectual disability where Black autistic children have significantly more co-occurrences than White autistic children. The purpose of this commentary is to first examine the assertion that the narrowed gap indicates, \"…improved…access to services among historically underserved groups,\" (p. 9) (Maenner et al., 2023. Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C.: 2002), 72, 1-14.). We will then recommend strategies to address the ongoing disparities.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    单纯疱疹病毒2型(HSV-2)是一种性传播感染,影响全球4.91亿人。因此,非常需要预防性和治疗性疫苗。不幸的是,几个疫苗临床试验,主要使用HSV-2的糖蛋白D(gD-2),失败了。人类抗HSV-2抗体在生殖器感染和疾病中赋予的免疫保护仍然难以捉摸。众所周知,gD-2引发交叉反应性中和抗体,即,抗gD-2抗体识别HSV-1(gD-1)中的gD。相比之下,HSV-2(mgG-2)抗体中的抗糖蛋白G对HSV-2具有唯一的类型特异性。在这项研究中,在哺乳动物细胞中重组产生gD-2和mgG-2的截短形式,并用于从五名HSV-2感染受试者的血清中纯化抗gD-2和抗mgG-2抗体,创造了一个纯化的抗体池。这些抗体库与纯化的mgG-2和gD-2抗原一起用作ELISA中的标准,以定量估计和比较交叉反应性抗gD-1和抗gD-2抗体的水平。以及HSV-1+2-血清中的抗mgG-2抗体,HSV-2-,和HSV-1感染的受试者。与交叉反应性抗gD-1和抗gD-2抗体相比,HSV-1+2感染受试者中抗mgG-2抗体的中位浓度低五倍,与抗gD-2抗体相比,在HSV-2感染的受试者中降低了三倍。纯化的抗gD-2抗体池在低浓度下呈现中和活性,而纯化的抗mgG-2抗体库没有。相反,这些抗mgG-2抗体通过人粒细胞介导的抗体依赖性细胞毒性(ADCC),单核细胞,和NK细胞,但没有显示补体依赖性细胞毒性。这些发现表明,在HSV-2感染的受试者中,mgG-2抗体以低浓度存在,但通过ADCC而不是通过中和游离病毒颗粒介导对感染细胞的杀伤。我们,和其他人,推测在HSV-2疫苗接种后,Fc受体介导的抗体功能如ADCC可作为保护相关而不是中和活性的更好标记。在mgG-2治疗性疫苗中,我们发现HSV-2感染受试者中抗mgG-2抗体水平较低,这可能提示我们有机会增强针对mgG-2的免疫应答.在预防性HSV-2mgG-2疫苗中,在已经感染的HSV-1受试者中,交叉反应免疫应答的可能干扰是可以避免的.
    Herpes simplex virus 2 (HSV-2) is a sexually transmitted infection affecting 491 million individuals globally. Consequently, there is a great need for both prophylactic and therapeutic vaccines. Unfortunately, several vaccine clinical trials, primarily employing the glycoprotein D of HSV-2 (gD-2), have failed. The immune protection conferred by human anti-HSV-2 antibodies in genital infection and disease remains elusive. It is well-known that gD-2 elicits cross-reactive neutralizing antibodies, i.e., anti-gD-2 antibodies recognize gD in HSV-1 (gD-1). In contrast, anti-glycoprotein G in HSV-2 (mgG-2) antibodies are exclusively type-specific for HSV-2. In this study, truncated versions of gD-2 and mgG-2 were recombinantly produced in mammalian cells and used for the purification of anti-gD-2 and anti-mgG-2 antibodies from the serum of five HSV-2-infected subjects, creating a pool of purified antibodies. These antibody pools were utilized as standards together with purified mgG-2 and gD-2 antigens in ELISA to quantitatively estimate and compare the levels of cross-reactive anti-gD-1 and anti-gD-2 antibodies, as well as anti-mgG-2 antibodies in sera from HSV-1+2-, HSV-2-, and HSV-1-infected subjects. The median concentration of anti-mgG-2 antibodies was five times lower in HSV-1+2-infected subjects as compared with cross-reactive anti-gD-1 and anti-gD-2 antibodies, and three times lower in HSV-2 infected subjects as compared with anti-gD-2 antibodies. The pool of purified anti-gD-2 antibodies presented neutralization activity at low concentrations, while the pool of purified anti-mgG-2 antibodies did not. Instead, these anti-mgG-2 antibodies mediated antibody-dependent cellular cytotoxicity (ADCC) by human granulocytes, monocytes, and NK-cells, but displayed no complement-dependent cytotoxicity. These findings indicate that antibodies to mgG-2 in HSV-2-infected subjects are present at low concentrations but mediate the killing of infected cells via ADCC rather than by neutralizing free viral particles. We, and others, speculate that Fc-receptor mediated antibody functions such as ADCC following HSV-2 vaccination may serve as a better marker of protection correlate instead of neutralizing activity. In an mgG-2 therapeutic vaccine, our findings of low levels of anti-mgG-2 antibodies in HSV-2-infected subjects may suggest an opportunity to enhance the immune responses against mgG-2. In a prophylactic HSV-2 mgG-2 vaccine, a possible interference in cross-reactive immune responses in already infected HSV-1 subjects can be circumvented.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号